1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
2 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | 0 | - |
| Net profit | 386.41K | 141.98% |
| EBITDA | 455.63K | 151.54% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €200.3K |
Number of shares | 138.08K |
52-week high/low | €19.00 - €1.00 |
| Dividends | No |
Beta | -0.54 |
P/E ratio | -0.01 |
PEG ratio | 0.00 |
P/B ratio | 0.59 |
P/S ratio | 0.00 |
Company profile
| Name | Purple Biotech ADR |
| CEO | Gil Efron |
| Employees | 10 |
Discover assets
Shareholders of Purple Biotech ADR also invest in the following assets
